Clinical Trial Update: Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

This ClinicalTrials.gov entry reports a Phase 2 study evaluating Ivonescimab in patients with cutaneous squamous cell carcinoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Squamous Cell Carcinoma

Drugs mentioned

• Ivonescimab (AK112/SMT112)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Cutaneous Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING